VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 26 filers reported holding VASCULAR BIOGENICS LTD in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,014,000 | -59.7% | 452,677 | -50.2% | 0.00% | -66.7% |
| Q1 2017 | $5,000,000 | +13.4% | 909,091 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $4,409,000 | -7.1% | 909,091 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,745,000 | +13.2% | 909,091 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $4,191,000 | – | 909,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spectrum Planning & Advisory Services Inc. | 16,000 | $2,681 | 0.00% |
| Virtu Financial LLC | 37,424 | $6 | 0.00% |
| Affinity Capital Advisors, LLC | 22,265 | $3,729 | 0.00% |
| MORGAN STANLEY | 409,011 | $68,509 | 0.00% |
| HBK Sorce Advisory LLC | 20,575 | $3,447 | 0.00% |
| Bank of New York Mellon Corp | 39,000 | $6,533 | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 11,000 | $2 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 937 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 798 | $0 | 0.00% |